Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Gus J. Vlahakes, M.D.


This page shows the publications co-authored by Gus Vlahakes and Robert Levine.
Connection Strength

  1. Mechanistic insights into functional mitral regurgitation. Curr Cardiol Rep. 2002 Mar; 4(2):125-9.
    View in: PubMed
    Score: 0.240
  2. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ Heart Fail. 2010 Sep; 3(5):627-34.
    View in: PubMed
    Score: 0.107
  3. A novel approach for reducing ischemic mitral regurgitation by injection of a polymer to reverse remodel and reposition displaced papillary muscles. Circulation. 2008 Sep 30; 118(14 Suppl):S263-9.
    View in: PubMed
    Score: 0.095
  4. Mitral leaflet adaptation to ventricular remodeling: occurrence and adequacy in patients with functional mitral regurgitation. Circulation. 2008 Aug 19; 118(8):845-52.
    View in: PubMed
    Score: 0.094
  5. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol. 2008 Jan 29; 51(4):476-86.
    View in: PubMed
    Score: 0.090
  6. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study. Circulation. 2007 Sep 11; 116(11 Suppl):I288-93.
    View in: PubMed
    Score: 0.088
  7. The crossed swords sign: insights into the dilemma of repair in bileaflet mitral valve prolapse. J Am Soc Echocardiogr. 2007 Jun; 20(6):698-702.
    View in: PubMed
    Score: 0.086
  8. Chordal cutting does not adversely affect left ventricle contractile function. Circulation. 2006 Jul 04; 114(1 Suppl):I524-8.
    View in: PubMed
    Score: 0.081
  9. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation. 2003 Sep 09; 108 Suppl 1:II111-5.
    View in: PubMed
    Score: 0.067
  10. Determinants of maximal right ventricular function: role of septal shift. J Thorac Cardiovasc Surg. 2002 Jan; 123(1):72-80.
    View in: PubMed
    Score: 0.059
  11. Application of polymer-mesh device to remodel left ventricular-mitral valve apparatus in ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2018 04; 155(4):1485-1493.
    View in: PubMed
    Score: 0.045
  12. Efficacy of polymer injection for ischemic mitral regurgitation: persistent reduction of mitral regurgitation and attenuation of left ventricular remodeling. JACC Cardiovasc Interv. 2015 Feb; 8(2):355-363.
    View in: PubMed
    Score: 0.037
  13. Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repair. Circulation. 2013 Sep 10; 128(11 Suppl 1):S248-52.
    View in: PubMed
    Score: 0.033
  14. Polymer injection therapy to reverse remodel the papillary muscles: efficacy in reducing mitral regurgitation in a chronic ischemic model. Circ Cardiovasc Interv. 2010 Oct; 3(5):499-505.
    View in: PubMed
    Score: 0.027
  15. Mitral leaflet adaptation to ventricular remodeling: prospective changes in a model of ischemic mitral regurgitation. Circulation. 2009 Sep 15; 120(11 Suppl):S99-103.
    View in: PubMed
    Score: 0.025
  16. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2007 Dec 01; 100(11):1691-5.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.